This week in research news: teasing out genetic clues across the skeleton, a "missing mutation" in infant epilepsy, and studying soy-based baby formulas.
The purpose of this research is to investigate study drug IW-6463 in patients with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS).
The Ganetzky Lab focuses on inherited mitochondrial respiratory chain disorders with a goal of applying biochemical approaches to develop improved diagnostic modalities, especially for mitochondrial Complex V (ATP Synthase) deficiency.
